loadpatents
Patent applications and USPTO patent grants for Pawar; Shantaram.The latest application filed is for "parenteral dosage form of norepinephrine".
Patent | Date |
---|---|
Parenteral dosage form of norepinephrine Grant 11,166,923 - Thummar , et al. November 9, 2 | 2021-11-09 |
Parenteral Dosage Form Of Norepinephrine App 20180140563 - THUMMAR; Rakesh ;   et al. | 2018-05-24 |
Parenteral dosage form of amiodarone Grant 9,757,352 - Rana , et al. September 12, 2 | 2017-09-12 |
Parenteral Dosage Form Of Amiodarone App 20170216243 - RANA; Amar Kishorbhai ;   et al. | 2017-08-03 |
Parenteral dosage form of amiodarone Grant 9,642,828 - Rana , et al. May 9, 2 | 2017-05-09 |
Parenteral Dosage Form Of Amiodarone App 20160081972 - RANA; Amar Kishorbhai ;   et al. | 2016-03-24 |
Octreotide Injection App 20140213984 - PAWAR; Shantaram ;   et al. | 2014-07-31 |
Octreotide Injection App 20130303453 - PAWAR; Shantaram ;   et al. | 2013-11-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.